Abstract
Colorectal cancer is one of the most prevalent malignancies in the world. Chinese researchers and clinical doctors had been working hard in the last 12 years, exploring efficient and convenient methods for screening and early diagnosis. The 12 years research works indicated that SFOBT plus colonoscopy was the best detecting protocol for mass screening of colorectal cancer. Serial combined testing for tumor markers plus colonoscopy is the most commonly used strategy for early diagnosis. However, still no optimum method for early diagnosis was generally accepted by most researchers. Due to intrinsic defects of the techniques, several screening and diagnostic methods should be combined to bring each advantage into full play, in order to elevate the diagnostic level of colorectal cancer.
Similar content being viewed by others
References
Bai L, Lai ZS, Zhou DY et al (1998) Soluble tumor necrosis factor (sTNF) receptor I in patients with colorectal cancer. Cancer (China) 17:93–95
Cao LY, Zhang HF, Gong XY et al (1999) Quantitative study on the expression of p53 and PCNA in colorectal tumor. J Prac Tumor 13:257–258
Cao LY, ZhangHF, Meng G et al (2000) Significance and expression of bcl-2 and PCNA in colorectal tumor. J Clinic Tumor 5:85–87
Chen H, He QL, Yu YL et al (2002) Relationship between detection of p53 gene in peripheral blood and early diagnosis of colorectal cancer. Guangdong Med 23:1269–1270
Chen YL, Liao QF, Zhuang ZH et al (1996) Detection and clinical significance of serum gastrin and carcinoembryonic antigen in patients with colorectal cancers. J Fujian Medical College 30:350–353
Chen L, Lu S, Wang HH et al (1998) Significance of quantitative assay of gene product of p53 in the early diagnosis of colorectal cancer. J Dalian Medical University 20:14–15
Colorectal cancer cooperative group, Beijing society of gastroenterology, Chinese medical association. Comparative analysis of patients with colorectal cancer clinically diagnosed in hospital with those detected by mass screening. World J Gastroenterol 2004;9:145–149
Fan RY, Li SR, Wu X et al (2001) Role of exfoliated epithelial cells in feces in diagnosis of colorectal caicinoma. J Diagn Pathol 8:277–279
Fan RY, Li SR, Wu ZT et al (2002) Colorectal exfoliated cell in stool and its nuclear quantitative analysis for diagnosis of colorectal cancer. Cancer (China) 21:776–780
Feng FC, Huang W, Zhou DY et al (1995) Study on detection of cancer associated antigen in serum and feces by monoclonal antibodies against human colorectal cancer. World Chin J Gastroenterol 3:36–38
Feng H, Song JD (2002) Significance of colorectal carcinoma-associated antigen LEA in diagnosis of patients with colorectal cancer. Chin J Immunol 18:539–542
Guo WJ, Wu HJ, Liu YQ et al (1999) The value of GST-pi in the early diagnosis of colorectal cancer. J Weifang College 21:3–5
Hu FY, Song JD, Wang YQ (2002) Expression of tumor related antigen-LEA in patients serum of colorectal carcinoma and colorectal non-carcinoma. Prog Anat Sci 8:6–8
Ji ZZ, Zhan LY (2003) Value of combined assay of tumor markers in diagnosis and following with large intestinal cancer. Chin J Gastroenterol Hepatol 12:375–378
Jia SJ, Feng XH, Rao XS (2003) Significance and expression of p53, C-erbB-2 and PCNA in the biopsy tissue of colonoscope. Chin New Med 4:102–104
Li SR (1993) Application of sequential procedure for fecal occult blood test in the screening of colorectal cancer: screening results from 12,800 asymptomatic populations. Zhonghua Zhong Liu Za Zhi 15:230–232
Li SR, Chen ZM, Liu DQ et al (1997) A comparative study of the efficiency and expense associated with mass screening programs of colorectal neoplasms in high risk populations. China J Endosc 3:16–18
Li LJ, Du WS, Feng CZ et al (2001) Diagnosis of colorectal cancer by using anti-colorectal cancer monoclonal antibody. Chin J Clin Rehabil Tumor 8:5–7
Li J, Li SR, Gao G et al (2000a) Laser-induced fluorescence (LIF) spectrum of colorectal cancer in vivo. Zhong Hua Zhong Liu Za Zhi 22:398–400
Li J, Li SR, Gao G et al (2000b) Laser-induced fluorescence and colorectal cancer diagnosis. Zhong Hua Hsiao Hua Tsa Chih 20:95–98
Li SR, Liu DQ, Yue YW et al (1990) Evaluation of serial fecal occult blood test for the mass screening of colorectal cancer. Zhonghua Laonian Yixue Za Zhi 9:152–154
Li SR, Nie ZH, Li N et al (2002) Reassessment on the screening program of colorectal cancer by the sequential fecal occult blood test. Zhong Hua Hsiao Hua Tsa Chih 22:395–397
Li XL, Sun DC (2003) Significance of combined detection of serum tumor markers in diagnosis of colorectal cancer. Clin Med China 19:738–739
Li SR, Tian SL, Wu ZT et al (2004) Application of sequential fecal occult blood test in consecutive screening of colorectal cancer carcinoma for natural population. World J Gastroenterol 12:137–139
Li SR, Zhang CL, Xu ED et al (1995a) Evaluation of combined test of sequential fecal occult blood and albumin in the screening of colorectal neoplasm. Zhonghua Zhong Liu Za Zhi 17:381–383
Liu SC, Bai X, Wei RG et al (2000) Reresearch of galactose oxidase in screening carcinoma of the large intestine. Guangxi Med J 22:11–12
Liu SC, Li EJ, Bai X et al (1995b) Diagnostic significance of galactose oxidase in screening carcinoma of the large intestine. Guangxi Med J 17:183–184
Liu Q, Liu SE, Gao ML et al (2003) Clinical study on the relationship between the p53 gene examination and colorectal neoplasm. Zhong Hua Nei Ke Za Zhi 5:58–60
Liu JT, Qin EP, Cui XB et al (1995) Clinical significance of detection the T-antigen of rectal mucus. J Inner Mong Med 15:333–334
Liu BY, Sun AL, Pan SW et al (2000) Expression and significance of early diagnosis of colorectal cancer related genes. World J Gastroentrol 8(S:S):43
Liu XY, Zheng S, Chen K et al (2000) Randomized controlled trial of sequence mass screening program for colorectal cancer. Chin J Epidemiol 21:430–433
Liu XY, Zheng S, Yang G et al (1997) Evaluation of optimized screening protocol for colorectal cancer among a high-incidence population. Zhongliu Fangzhi Yanjiu 24:197–200
Luo DC, Dai HJ, Ni YZ (1998) A study on the screening of large intestinal carcinoma by T-antigen monoclonal antibody method. China Oncol 8:256–257
Qin J, Zhang Q, Fang XZ et al (1997) Cinical significance of galactose oxidase-schiff reaction in the detection of carcinoma and precacerous lesions of large intestine. Zhong Hua Zhong Liu Za Zhi 19:157–159
Qiu SL, Huang JQ (1997) Significance of CD44 gene product in the diagnosis and prognosis of colorectal cancer. World J Gastroenterol 5(S:S):32–33
Qiu SL, Huang JQ, Wang YF et al (1998) Analysis of telomerase activity in colorectal cancer, precancerous lesions and cancer washings. World J Gastroenterol 6:992–993
Qiu SL, Liu BR, Zhou XG (2002) Quantitative analysis of DNA content and morphology of colorectal carcinoma. Acta Universitatis Medicinalis Secondae Shanghai 22:11–15
Qiu PL, Zheng S, Wu JM et al (1997) Application of colonofiberscope on screening of colorectal cancer: analyzing of 3359 persons. Chin J Endosc 3:51–52
Ren ZP, Shi Z, Chen WL et al (2000) Study on the expression of HPV16, 18E6, p53 and ras in colorectal tumor. Chin J Clin Rehabil Tumor 7:22–24
Sheng XZ, Shen PY, Mu QL et al (2001) Relationship between multi-gene variation in fecal exfoliative cells and the early diagnosis of colorectal cancer. Shandong Med 41:4–6
Su R, Tang Y, Li H et al (2002) Clinical significance and serum gastrinemia in patients with colorectal cancer. J Prac Med 18:1047–1048
Sun QX, Li WD, Shen YZ et al (1996) Evaluation of detection T-antigen on screening colorectal cancer by GOS kit in rectal mucus. J Pract Tumor 11:115–116
Sun YQ, Lu MK, Li LQ et al (1997) Early diagnosis carcinoma of the large intestine by examing the intestinal mucosa flora. Chin J Microecol 9:21–22
Tong LH, Wu YX, Su XL (2001) Significance and expression of p53 and Bcl-2 in colorectal cancer. J Inner Mong College 23:158–163
Wang ZY, Zhao JW, Wang XP et al (2000) Tumor related genes on clinical diagnosis and prognosis application of large intestine tumors. J Beihua University (natural science) 1:122–124
Wu XW, Li SR, Wang ZH et al (1997) The evaluation of colonic exfoliative cell for the screening of colorectal cancer Cancer (China) 16:386–387
Wu ZT, Wang ZH, Li SR et al (1995) Reassessment of sequential fecal blood test on screening colorectal cancer. Shiyong Zhongliu Za Zhi 10:223–224
Xu N, Qiu HM, Ding YQ (1998) The relation between DNA replication error and clinicopathological features of colorectal carcinoma. Zhonghua Bing Li Xue Za Zhi 27:359–361
Xu WQ, Zhao YF, Tang JM (2001) Expression and significance of telomerase RNA in colorectal carcinoma. J Clinic Exp Pathol 17:201–204
Yi P, Sun Qi, Xun YH et al (2000) Analysis of the expression of p53 and C-erbB-2 in colorectal cancer. J Guangxi Medical University 17:276–277
Yi P, Sun Q, Xu YH et al (1999) Analysis of the expression of P53 and C-erbB-2 in colorectal cancer. J Dis Large intestine and anus 5:17–18
Yu SP, Zheng Sj, Zhou HY et al (1998) The value of fecal colloidal gold immunization on screening of colorectal cancer. Guangdong Medicine 19:224
Yu SP, Zhou HY, Dai WH et al (2002) Efffects of screening of colorectal cancer by colonofiberscope. Chin J Dig 22:121–122
Zeng K, Tuo ZF (1998) Progression of clinical application of light biopsy. Zhong Hua Zhong Liu Za Zhi 20:471–472
Zhang HG, Li SR, Chen ZM et al (1999) Necessity and feasibility of mass screening of colorectal neoplasma for aged individuals. Chin J Gastroenterol Hepatol 8:214–215
Zhao ZX, Guo M, Sun L (1999) Clinical significance of T-antigen assay in the diagnosis of colorectal cancinoma. Acta Acad Med CPAPF 8:148–149
Zhao DB, Zhang W, Jin SQ et al (1998) Study of telomerase activity in colorectal carcinomas. Zhong Hua Zhong Liu Za Zhi 20:199–201
Zheng S, Chen K, Liu XY, Ma XY, Yu H, Chen K, Yao KY (2003) Cluster randomization trial of sequence mass screening for colorectal cancer. Dis Colon Rectum (46):51–58
Zheng CD, Wu DC, Zhang L et al (1998) Clinical significance by testing rectal mucus T-antigen to colorectal cancer. J Clin Dig Dis 10:16–18
Zhou DY, Feng FC, Zhang YL et al (1994) Study on protocol of complementary screening on colorectal cancer. Zhonghua Nei Ke Za Zhi 33:367–369
Zhou L, Yu H, Zheng S (1997) The verification of optimized screening protocol for colorectal cancer in general population of high-incidence area. Chin J Prev Control Chronic Dis 5:75–76
Zhu CL, Nie M, Zhu YH (1997) Application of detection disaccharide residue in colorectal mucus on screening colorectal cancer. J Qinghai Med College 18:260
Zhu YF, Zhu JX, Xu JY et al (1997) Expression of p53 protein in early colorectal cancer. J Prac Tumor 12:73–74
Zhuo Y, Ma F (1999) Study on detection of intestinal mucosa flora for the screening of colorectal cancer. Chin J Microecol 11:275
Zou HZ, Yu BM, Zhao R et al (2002) Detection of aberrant p16 methylation in the serum of colorectal cancer patients. Zhong Hua Wai Ke Za Zhi 40:499–501
Acknowledgments
This study was supported by a grant from department of Gastroenterology, Beijing Army General Hospital and State Key laboratory of Cancer Biology and Institute of Digestive Diseases, colorectal cancer research cooperative program.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Li, S., Wang, J., Lu, Y. et al. Screening and early diagnosis of colorectal cancer in China: a 12 year retrospect (1994–2006). J Cancer Res Clin Oncol 133, 679–686 (2007). https://doi.org/10.1007/s00432-007-0231-z
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00432-007-0231-z